Literature DB >> 19465471

Procedures for ethical review for clinical trials within the EU.

Andreas A Schnitzbauer1, Philipp E Lamby, Ingrid Mutzbauer, Carl Zuelke, Hans J Schlitt, Edward K Geissler.   

Abstract

Mesh:

Year:  2009        PMID: 19465471     DOI: 10.1136/bmj.b1893

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Ask not what your REB can do for you; ask what you can do for your REB.

Authors:  Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

Review 2.  [Challenges in the organization of investigator initiated trials: in transplantation medicine].

Authors:  A A Schnitzbauer; P E Lamby; I Mutzbauer; J von Hassel; E K Geissler; H J Schlitt
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

3.  A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  Andreas A Schnitzbauer; Carl Zuelke; Christian Graeb; Justine Rochon; Itxarone Bilbao; Patrizia Burra; Koert P de Jong; Christophe Duvoux; Norman M Kneteman; Rene Adam; Wolf O Bechstein; Thomas Becker; Susanne Beckebaum; Olivier Chazouillères; Umberto Cillo; Michele Colledan; Fred Fändrich; Jean Gugenheim; Johann P Hauss; Michael Heise; Ernest Hidalgo; Neville Jamieson; Alfred Königsrainer; Philipp E Lamby; Jan P Lerut; Heikki Mäkisalo; Raimund Margreiter; Vincenzo Mazzaferro; Ingrid Mutzbauer; Gerd Otto; Georges-Philippe Pageaux; Antonio D Pinna; Jacques Pirenne; Magnus Rizell; Giorgio Rossi; Lionel Rostaing; Andre Roy; Victor Sanchez Turrion; Jan Schmidt; Roberto I Troisi; Bart van Hoek; Umberto Valente; Philippe Wolf; Heiner Wolters; Darius F Mirza; Tim Scholz; Rudolf Steininger; Gunnar Soderdahl; Simone I Strasser; Karl-Walter Jauch; Peter Neuhaus; Hans J Schlitt; Edward K Geissler
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

4.  Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.

Authors:  Otto Metzger-Filho; Evandro de Azambuja; Ian Bradbury; Kamal S Saini; José Bines; Sergio D Simon; Veerle Van Dooren; Gursel Aktan; Kathleen I Pritchard; Antonio C Wolff; Ian Smith; Christian Jackisch; Istvan Lang; Michael Untch; Frances Boyle; Binghe Xu; Jose Baselga; Edith A Perez; Martine Piccart-Gebhart
Journal:  Oncologist       Date:  2013-01-28

5.  Guillain-Barré syndrome in times of pandemics.

Authors:  Sonja E Leonhard; David R Cornblath; Hubert P Endtz; James J Sejvar; Bart C Jacobs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-30       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.